Viela Bio receives FDA approval for autoimmune treatment

The treatment, called Uplizna, received breakthrough status from the FDA in August 2019.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.